Utilizing Autologous Multipotent Mesenchymal Stromal Cells and -Tricalcium Phosphate Scaffold in Human Bone Defects: A Prospective, Controlled Feasibility Trial

Figure 7

Corresponding coronal CT scan obtained for the same patient shown in previous figures (case number 6; trial group) at 12 months after surgery; the defect was filled with tricalcium phosphate synthetic graft material combined with expanded multipotent mesenchymal stromal cells (MSCs). The medial femoral bone defect is nearly completely filled with newly formed bone tissue (marked by an arrow).